NEW APPROACHES FOR TREATMENT IN DIABETES - ALDOSE REDUCTASE INHIBITORS

被引:57
作者
HOTTA, N
机构
[1] The Third Department of Internal Medicine, Nagoya University School of Medicine, Showa-ku, Nagoya, 466
关键词
POLYOL PATHWAY; DIABETIC COMPLICATIONS; NEUROPATHY; RETINOPATHY; ATHEROSCLEROSIS; INFECTION; NEUTROPHIL FUNCTION; RED BLOOD CELL 2,3-DIPHOSPHOGLYCERATE;
D O I
10.1016/0753-3322(96)82629-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
[No abstract available]
引用
收藏
页码:232 / 243
页数:12
相关论文
共 170 条
[111]  
MORRISON AD, 1985, DIABETES S1, V34, pA12
[112]   LONG-TERM COMPLICATIONS OF DIABETES-MELLITUS [J].
NATHAN, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (23) :1676-1685
[113]   INHIBITION OF POLYMORPHONUCLEAR LEUKOCYTE RESPIRATORY BURST BY ELEVATED GLUCOSE-CONCENTRATIONS INVITRO [J].
NIELSON, CP ;
HINDSON, DA .
DIABETES, 1989, 38 (08) :1031-1035
[114]   TOLRESTAT, AN ALDOSE REDUCTASE INHIBITOR, PREVENTS NERVE DYSFUNCTION IN CONSCIOUS DIABETIC RATS [J].
NOTVEST, RR ;
INSERRA, JJ .
DIABETES, 1987, 36 (04) :500-504
[115]   EFFECT OF DIABETES ON CYTOSOLIC FREE CA2+ AND NA+-K+-ATPASE IN RAT AORTA [J].
OHARA, T ;
SUSSMAN, KE ;
DRAZNIN, B .
DIABETES, 1991, 40 (11) :1560-1563
[116]   ALDOSE REDUCTASE INHIBITION IN DIABETIC NEUROPATHY - CLINICAL AND NEUROPHYSIOLOGICAL STUDIES OF ONE YEARS TREATMENT WITH SORBINIL [J].
OHARE, JP ;
MORGAN, MH ;
ALDEN, P ;
CHISSEL, S ;
OBRIEN, IAD ;
CORRALL, RJM .
DIABETIC MEDICINE, 1988, 5 (06) :537-542
[117]   LOCALIZATION OF ALDOSE REDUCTASE AND SORBITOL DEHYDROGENASE IN THE NERVOUS-SYSTEM OF NORMAL AND DIABETIC RATS [J].
OROSZ, SE ;
TOWNSEND, SF ;
TORNHEIM, PA ;
BROWNSCHEIDLE, CM .
ACTA DIABETOLOGICA LATINA, 1981, 18 (04) :373-381
[118]  
PATILES MB, 1982, INVEST OHTHALMOL VIS, V22, P174
[119]   CP-45,634 - NOVEL ALDOSE REDUCTASE INHIBITOR THAT INHIBITS POLYOL PATHWAY ACTIVITY IN DIABETIC AND GALACTOSEMIC RATS [J].
PETERSON, MJ ;
SARGES, R ;
ALDINGER, CE ;
MACDONALD, DP .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1979, 28 (04) :456-461
[120]  
PFEIFER M, 1986, DIABETES, V35, pA102